References
Mallolas J, Zamora L, Gatell JM, Miro JM, Vernet E, Valls ME et al. Primary Prophylaxis for PCP: a randomized trial comparing cotrimoxazole, aerosolized Pentamidine and dapsone plus pyrimethamine. AIDS 1993; 7: 59–64.
Eric Caumes, Francois Lheriteau, Marc Gentilini Cotrimoxazole Prophylaxis for Toxoplasmosis. Annals of Internal Medicine 1993; 118: 395.
Merchant RH, Oswal JS, Bhagwat RV, Karkare J. Clinical profile of HIV infection. Indian Pediatr 2001; 38: 239–246.
World Health Organization. Interim WHO Clinical Staging of HIV/AIDS and HIV/AIDS Case Definitions for Surveillance. 2005. Available at: http://www.who.int/hiv/pub/guidelines/casedefinitions/en/index.html .
Dworkin MS, Williamson F, Jones JL, Kaplan JE. Adult and Adolescent Spectrum of HIV Disease Project. Prophylaxis with trimethoprim-Sulfamethoxazole for HIV Infected patients: impact on risk for infectious diseases. Clin Infect Dis 2001; 33: 393–398.
Chintu C, Bhat GJ, Walker AS, Mulenga V, Sinyinza F, Farrelly L et al. Co-trimoxazole as prophylaxis against opportunistic infections as HIV-infected Zambian children (CHAP): a double-blind randomized placebo-controlled trial. Lancet 2004; 364: 1865–1871.
Coutsoudis A, Pillay K, Spooner E, Coovadia HM, Pembrey L, Newell ML. Routinely available cotrimoxazole prophylaxis and occurrence of respiratory and Diarrhoeal morbidity in infants born to HIV-infected mothers in South Africa. S Afr Med J 2005; 95: 339–345.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bandyopadhyay, A., Bhattacharyya, S. Daily cotrimoxazole prophylaxis in HIV infected children. Indian J Pediatr 76, 108–110 (2009). https://doi.org/10.1007/s12098-009-0127-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-009-0127-9